BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29102109)

  • 1. Molecular resistance mechanisms of Mycoplasma agalactiae to macrolides and lincomycin.
    Prats-van der Ham M; Tatay-Dualde J; de la Fe C; Paterna A; Sánchez A; Corrales JC; Contreras A; Gómez-Martín Á
    Vet Microbiol; 2017 Nov; 211():135-140. PubMed ID: 29102109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity and variation in antimicrobial susceptibility patterns over time in Mycoplasma agalactiae isolates collected from sheep and goats in France.
    Poumarat F; Gautier-Bouchardon AV; Bergonier D; Gay E; Tardy F
    J Appl Microbiol; 2016 May; 120(5):1208-18. PubMed ID: 26835882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibilities of field isolates of Mycoplasma agalactiae.
    Antunes NT; Tavío MM; Assunção P; Rosales RS; Poveda C; de la Fé C; Gil MC; Poveda JB
    Vet J; 2008 Sep; 177(3):436-8. PubMed ID: 17604191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short communication: In vitro antimicrobial susceptibility of Mycoplasma agalactiae strains isolated from dairy goats.
    Paterna A; Sánchez A; Gómez-Martín A; Corrales JC; De la Fe C; Contreras A; Amores J
    J Dairy Sci; 2013; 96(11):7073-7076. PubMed ID: 24035026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibilities of field isolates of Mycoplasma agalactiae to oxytetracycline, tylosin, enrofloxacin, spiramycin and lincomycin-spectinomycin.
    Loria GR; Sammartino C; Nicholas RA; Ayling RD
    Res Vet Sci; 2003 Aug; 75(1):3-7. PubMed ID: 12801456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 23S rRNA and L22 ribosomal protein are involved in the acquisition of macrolide and lincosamide resistance in Mycoplasma capricolum subsp. capricolum.
    Prats-van der Ham M; Tatay-Dualde J; Gómez-Martín Á; Corrales JC; Contreras A; Sánchez A; de la Fe C
    Vet Microbiol; 2018 Mar; 216():207-211. PubMed ID: 29519518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The moderate drift towards less tetracycline-susceptible isolates of contagious agalactia causative agents might result from different molecular mechanisms.
    Prats-van der Ham M; Tatay-Dualde J; Ambroset C; De la Fe C; Tardy F
    Vet Microbiol; 2018 Jul; 220():39-46. PubMed ID: 29885799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Susceptibility to Macrolide-Lincosamide in Mycoplasma synoviae Is Associated with Mutations in 23S Ribosomal RNA.
    Lysnyansky I; Gerchman I; Flaminio B; Catania S
    Microb Drug Resist; 2015 Dec; 21(6):581-9. PubMed ID: 25734368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibilities of caprine Mycoplasma agalactiae field isolates to six antimicrobial agents using the E test methodology.
    Filioussis G; Petridou E; Giadinis ND; Kritas SK
    Vet J; 2014 Dec; 202(3):654-6. PubMed ID: 25439442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired resistance to the 16-membered macrolides tylosin and tilmicosin by Mycoplasma bovis.
    Lerner U; Amram E; Ayling RD; Mikula I; Gerchman I; Harrus S; Teff D; Yogev D; Lysnyansky I
    Vet Microbiol; 2014 Jan; 168(2-4):365-71. PubMed ID: 24393633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycoplasma bovis isolates from dairy calves in Japan have less susceptibility than a reference strain to all approved macrolides associated with a point mutation (G748A) combined with multiple species-specific nucleotide alterations in 23S rRNA.
    Sato T; Higuchi H; Yokota SI; Tamura Y
    Microbiol Immunol; 2017 Jun; 61(6):215-224. PubMed ID: 28504455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the quinolone resistance determining region conferring resistance to fluoroquinolones in Mycoplasma agalactiae.
    Tatay-Dualde J; Prats-van der Ham M; de la Fe C; Paterna A; Sánchez A; Corrales JC; Contreras A; Gómez-Martín Á
    Vet Microbiol; 2017 Aug; 207():63-68. PubMed ID: 28757041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and detection of mutations potentially associated with decreased susceptibility to macrolides and lincomycin in Mycoplasma anserisalpingitidis isolates.
    Grózner D; Bekö K; Kovács ÁB; Mitter A; Hrivnák V; Sawicka A; Tomczyk G; Bányai K; Jánosi S; Kreizinger Z; Gyuranecz M
    Vet Microbiol; 2022 Mar; 266():109362. PubMed ID: 35144043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Mycoplasma agalactiae in Small Ruminants of Southeast Iran.
    Shamsaddini Bafti M; Pourbakhsh SA; Ezatkhah M; Ashtari A
    Arch Razi Inst; 2017 Dec; 72(4):237-242. PubMed ID: 30315700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro effect of six antimicrobials against Mycoplasma putrefaciens, Mycoplasma mycoides subsp. mycoides LC and Mycoplasma capricolum subsp. capricolum isolated from sheep and goats in Jordan.
    Al-Momani W; Nicholas RA; Janakat S; Abu-Basha E; Ayling RD
    Trop Anim Health Prod; 2006 Jan; 38(1):1-7. PubMed ID: 17405622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short communication: In vitro antimicrobial susceptibility of Mycoplasma bovis isolates identified in milk from dairy cattle in Belgium, Germany, and Italy.
    Barberio A; Flaminio B; De Vliegher S; Supré K; Kromker V; Garbarino C; Arrigoni N; Zanardi G; Bertocchi L; Gobbo F; Catania S; Moroni P
    J Dairy Sci; 2016 Aug; 99(8):6578-6584. PubMed ID: 27209138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VNTR analysis reveals unexpected genetic diversity within Mycoplasma agalactiae, the main causative agent of contagious agalactia.
    McAuliffe L; Churchward CP; Lawes JR; Loria G; Ayling RD; Nicholas RA
    BMC Microbiol; 2008 Nov; 8():193. PubMed ID: 18992155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Recombinant P48 of Mycoplasma agalactiae by Site Directed Mutagenesis and its Immunological Characterization.
    Cheema PS; Singh S; Kathiresan S; Kumar R; Bhanot V; Singh VP
    Anim Biotechnol; 2017 Jan; 28(1):11-17. PubMed ID: 27385225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of In Vivo acquired resistance of Mycoplasma hyopneumoniae to macrolides and lincosamides.
    Stakenborg T; Vicca J; Butaye P; Maes D; Minion FC; Peeters J; De Kruif A; Haesebrouck F
    Microb Drug Resist; 2005; 11(3):290-4. PubMed ID: 16201934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population structure and antimicrobial susceptibility of Mycoplasma ovipneumoniae isolates in France.
    Jaÿ M; Ambroset C; Tricot A; Colin A; Tardy F
    Vet Microbiol; 2020 Sep; 248():108828. PubMed ID: 32905961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.